MEDTRONIC NAVIGATION, INC (LITTLETON) O-ARM 1000 IMAGING SYSTEM 3RD EDITION; IMAGE-INTENSIFIED FLUOROSCOPIC X-RAY SYSTEM, M
|
Back to Search Results |
|
Model Number BI70000028120 |
Device Problems
Smoking (1585); Excessive Heating (4030)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 10/12/2023 |
Event Type
malfunction
|
Event Description
|
Medtronic received information regarding an imaging system being used outside of a procedure.It was reported that the system was parked and off and the site noticed a burning electrical smell coming from it so they unplugged it from the ac power. there was no patient involvement.
|
|
Manufacturer Narrative
|
Continuation of d10: section d information references the main component of the system.Other relevant device(s) are: product id: bi71000447, serial/lot #: -, ubd:- , udi#:-, product id: bi71000525, serial/lot #: -, ubd:- , udi#:-, product id: bi71000581 , serial/lot #: -, ubd:- , udi#:-, product id: bi71000526, serial/lot #: -, ubd:- , udi#:-, product id: bi71000525, serial/lot #: -, ubd:- , udi#:- h3, h6: no products have been returned to medtronic for analysis.Codes b17, c20, and d15 are applicable.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
H3,h6: a medtronic representative went to the site to test the equipment.Testing revealed that the battery charger boards, batteries and standalone board was replaced.The imaging system then passed the system checkout and was found to be fully functional.Codes b01,c02,d02 are applicable.Additional info: section e updated medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
H3, h6: the battery charger board, lot number: s1824xcu rev.B, was returned to the manufacturer for analysis.The battery charger board failed visual inspection.Transistor is broken off board.Codes b01, c07 and d02 are applicable to this analysis.The battery charger, lot number: s1338nfa rev.C, was returned to the manufacturer for analysis.The battery charge was found to be fully functional with no problem found.Battery charger pcbas passed bench test and visual inspection.Chargers output voltages were within inspection parameters.Installed battery charger in o-arm test system.The system initialized.Motion, generator, communication and charging readied.2d and 3d images readied.The reported event could not be duplicated by medtronic personnel.Codes b01, c19 and d14 are applicable to this analysis.The battery charger board, lot number: s1337lqt rev.C, was returned to the manufacturer for analysis.The battery charger board was found to be fully functional with no problem found.Battery charger pcbas passed bench test and visual inspection.Chargers output voltages were within inspection parameters.Installed battery charger in o-arm test system.The system initialized.Motion, generator, communication and charging readied.2d and 3d images readied.The reported event could not be duplicated by medtronic personnel.Codes b01, c19 and d14 are applicable to this analysis.The battery charger, lot number: s1338njf rev.C, was returned to the manufacturer for analysis.The battery charger was found to be fully functional with no problem found.Chargers output voltages were within inspection parameters.Installed battery charger in o-arm test system.The system initialized.Motion, generator, communication and charging readied.2d and 3d images readied.The reported event could not be duplicated by medtronic personnel.Codes b01, c19 and d14 are applicable to this analysis.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
H3/h6: product bi71000447, lot number s1348dkc rev.C , was returned and analyzed.Analysis determined that there was visual evidence of arcing.The complaint was confirmed.Codes b01, c02, and d02 apply.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|